Published in Vaccine Weekly, October 21st, 2009
So said Harry Glorikian, managing partner of Scientia Advisors, who announced the results of an in-depth study of the changing vaccine industry.
Scientia, based in Cambridge, MA and Palo Alto, CA, is a global management consulting firm specializing in growth strategies for major and emerging companies
"Novel vaccine design and delivery methods are changing vaccine industry dynamics," Glorikian said. "Large pharmaceutical companies, which today dominate 90...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly